This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

2 - 4 November 2021
Delivered in GMT time zone

Khadija Rantell
Senior Statistical Assessor at Medicines and Health Care Products Regulatory Agency (MHRA), UK


Dr Khadija Rantell (nee Rerhou) is a Senior Statistical Assessor in the Licensing Division of the Medicines and Healthcare products Regulatory Agency (MHRA). Prior to joining the MHRA in 2013, Khadija has been working in academia for over 10 years.

Khadija has many years of experience working as a statistician both in the academic and regulatory sectors. She has worked across a wide range of therapeutic areas. At the MHRA, she writes assessment reports on methodological aspects of licensing applications, advises companies on methodological aspects of their clinical development programme, and contributes to the assessment of clinical trial applications and clinical investigations of medical devices.

Khadija completed her PhD at the University of Sheffield in Applied Statistics to Health Services Research. She has a particular interest in early phase clinical trial designs, innovative trial designs (e.g. master protocols), patient reported outcomes, real-word-data, and rare diseases. She is a member of the Patient Reported Outcomes Specialist Interest Group at the MHRA, the EFSPI (European Federation for Statisticians in the Pharmaceutical Industry) Scientific Committee, and the EFPIA and the EFSPI Estimand Implementation Working Group (EIWG).

Agenda Sessions

  • Lessons Learnt from the Impact of the Pandemic on On-going Trials and Future Directions


Speakers at this event